Amylyx Pharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Summary

Amylyx Pharmaceuticals will present at the 11th Annual SVB Leerink Global Healthcare Conference on February 17, 2022, at 4:20 PM ET. Co-CEOs Joshua Cohen and Justin Klee will host the virtual presentation. Interested parties can access a live webcast through the Company’s investor section on their website, with a replay available for 90 days post-event.

Amylyx is focused on developing therapies for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) today announced that Joshua Cohen and Justin Klee, Co-CEOs and Co-Founders of Amylyx, will present at the 11^th Annual SVB Leerink Global Healthcare Conference. The conference is being conducted in a virtual format, and the presentation will take place on Thursday, February 17, 2022 at 4:20pm ET.

A live webcast of the presentation can be accessed under “Events” in the Investor section of the Company’s website, https://investors.amylyx.com/news-events/events, and will be available for replay for 90 days following the event.

About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. For more information, visit www.amylyx.com and follow us on LinkedIn and Twitter. For investors, please visit www.investors.amylyx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220210005251/en/

Media

Becky Gohsler

Finn Partners

(646) 307-6307

Becky.Gohsler@finnpartners.com

Investors

Lindsey Allen

Amylyx Pharmaceuticals, Inc.

(857) 320-6244

Investors@amylyx.com

Source: Amylyx Pharmaceuticals, Inc.

FAQ

What date will Amylyx Pharmaceuticals present at the SVB Leerink Global Healthcare Conference?

Amylyx Pharmaceuticals will present on February 17, 2022.

Who are the presenters for Amylyx Pharmaceuticals at the conference?

The presenters are Co-CEOs Joshua Cohen and Justin Klee.

What time is the Amylyx Pharmaceuticals presentation scheduled for?

The presentation is scheduled for 4:20 PM ET.

How can I watch the Amylyx Pharmaceuticals presentation?

The presentation can be accessed via a live webcast on the Company's investor section of their website.

What is the focus of Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals focuses on developing therapies for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.